Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Orchid Chemicals & Pharmaceuticals describes novel HDAC inhibitors as oncolytic compounds

May 28, 2009

Health Canada approves GSK's Tykerb in combination with Xeloda for breast cancer

May 27, 2009

FDA accepts Allos' pralatrexate NDA for filing and grants priority review

May 27, 2009

CTx progresses preclinical cancer drug against FAK enzyme into lead optimization phase

May 27, 2009

Bristol-Myers Squibb discloses androgen receptor antagonists for the treatment of cancer

May 27, 2009

Janssen claims novel PARP-1 inhibitors for cancer treatment

May 26, 2009

Schering-Plough describes novel kinesin spindle protein inhibitors for cancer treatment

May 25, 2009

Studies explore pharmacokinetics, antitumor activity of novel formulation of SN-38

May 25, 2009

P53-armed oncolytic adenovirus CGCT-04 induces apoptosis in cancer cells

May 25, 2009

Novel anti-EGFR antibody GA-201 active in tumor models

May 25, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...